Cargando…

Rationale for using centralized transduction inhibition assays in three phase 3 rAAV gene therapy clinical trials

Detalles Bibliográficos
Autores principales: Schulz, Martin, Bashirians, George, Cheng, Seng H., Levy, Daniel I., Lundie, Mark, Wilcox, Lisa, Winburn, Ian, Somanathan, Suryanarayan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585313/
https://www.ncbi.nlm.nih.gov/pubmed/37868207
http://dx.doi.org/10.1016/j.omtm.2023.101119

Ejemplares similares